0000950170-24-070620.txt : 20240607
0000950170-24-070620.hdr.sgml : 20240607
20240607161003
ACCESSION NUMBER: 0000950170-24-070620
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240606
FILED AS OF DATE: 20240607
DATE AS OF CHANGE: 20240607
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GRETHLEIN ANDREW J
CENTRAL INDEX KEY: 0001270921
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-20859
FILM NUMBER: 241029451
MAIL ADDRESS:
STREET 1: 651 GATEWAY BLVD STE 950
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GERON CORP
CENTRAL INDEX KEY: 0000886744
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 752287752
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 919 EAST HILLSDALE BOULEVARD
STREET 2: SUITE 250
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
BUSINESS PHONE: 6504737700
MAIL ADDRESS:
STREET 1: 919 EAST HILLSDALE BOULEVARD
STREET 2: SUITE 250
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
FORMER COMPANY:
FORMER CONFORMED NAME: GERON CORPORATION
DATE OF NAME CHANGE: 19960521
4
1
ownership.xml
4
X0508
4
2024-06-06
0000886744
GERON CORP
GERN
0001270921
GRETHLEIN ANDREW J
C/O GERON CORPORATION
919 E. HILLSDALE BLVD, SUITE 250
FOSTER CITY
CA
94404
false
true
false
false
EVP, Chief Operating Officer
false
Employee Stock Option (right to buy)
1.72
2024-06-06
4
A
false
452804
0
A
2028-11-06
Common Stock
452804
452804
D
Performance-based stock option granted on November 7, 2018 and vested in full on June 6, 2024 upon approval by the US FDA for imetelstat in lower risk MDS.
/s/ Scott A. Samuels for Andrew J. Grethlein
2024-06-07